Literature DB >> 22915820

Evidence for pH-dependent protease activity in the adeno-associated virus capsid.

Maxim Salganik1, Balasubramanian Venkatakrishnan, Antonette Bennett, Bridget Lins, Joseph Yarbrough, Nicholas Muzyczka, Mavis Agbandje-McKenna, Robert McKenna.   

Abstract

Incubation of highly purified adeno-associated virus (AAV) capsids in vitro at pH 5.5 induced significant autocleavage of capsid proteins at several amino acid positions. No autocleavage was seen at pH 7.5. Examination of other AAV serotypes showed at least two different pH-induced cleavage patterns, suggesting that different serotypes have evolved alternative protease cleavage sites. In contrast, incubation of AAV serotypes with an external protease substrate showed that purified AAV capsid preparations have robust protease activity at neutral pH but not at pH 5.5, opposite to what is seen with capsid protein autocleavage. Several lines of evidence suggested that protease activity is inherent in AAV capsids and is not due to contaminating proteins. Control virus preparations showed no protease activity on external substrates, and filtrates of AAV virus preparations also showed no protease activity contaminating the capsids. Further, N-terminal Edman sequencing identified unique autocleavage sites in AAV1 and AAV9, and mutagenesis of amino acids adjacent to these sites eliminated cleavage. Finally, mutation of an amino acid in AAV2 (E563A) that is in a conserved pH-sensitive structural region eliminated protease activity on an external substrate but did not seem to affect autocleavage. Taken together, our data suggested that AAV capsids have one or more protease active sites that are sensitive to pH induction. Further, it appears that acidic pHs comparable to those seen in late endosomes induce a structural change in the capsid that induces autolytic protease activity. The pH-dependent protease activity may have a role in viral infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915820      PMCID: PMC3486322          DOI: 10.1128/JVI.01717-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

Authors:  Sergei Zolotukhin; Mark Potter; Irene Zolotukhin; Yoshihisa Sakai; Scott Loiler; Thomas J Fraites; Vince A Chiodo; Tina Phillipsberg; Nicholas Muzyczka; William W Hauswirth; Terance R Flotte; Barry J Byrne; Richard O Snyder
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

3.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

4.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

5.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

Authors:  Michael A Lochrie; Gwen P Tatsuno; Brian Christie; Jennifer Wellman McDonnell; Shangzhen Zhou; Richard Surosky; Glenn F Pierce; Peter Colosi
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice.

Authors:  Glen A Farr; Susan F Cotmore; Peter Tattersall
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.

Authors:  A M Douar; K Poulard; D Stockholm; O Danos
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.

Authors:  Shaun R Opie; Kenneth H Warrington; Mavis Agbandje-McKenna; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  36 in total

Review 1.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

Review 2.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

Review 3.  AAV: An Overview of Unanswered Questions.

Authors:  Kenneth I Berns; Nicholas Muzyczka
Journal:  Hum Gene Ther       Date:  2017-04       Impact factor: 5.695

4.  AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations.

Authors:  Simon Pacouret; Mohammed Bouzelha; Rajani Shelke; Eva Andres-Mateos; Ru Xiao; Anna Maurer; Mathieu Mevel; Heikki Turunen; Trisha Barungi; Magalie Penaud-Budloo; Frédéric Broucque; Véronique Blouin; Philippe Moullier; Eduard Ayuso; Luk H Vandenberghe
Journal:  Mol Ther       Date:  2017-04-17       Impact factor: 11.454

5.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

6.  Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Authors:  Sarah C Nicolson; R Jude Samulski
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

7.  Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.

Authors:  Heather M Callaway; Kurtis H Feng; Donald W Lee; Andrew B Allison; Melissa Pinard; Robert McKenna; Mavis Agbandje-McKenna; Susan Hafenstein; Colin R Parrish
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

8.  Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes.

Authors:  Maxim Salganik; Fikret Aydemir; Hyun-Joo Nam; Robert McKenna; Mavis Agbandje-McKenna; Nicholas Muzyczka
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

Review 10.  Cellular transduction mechanisms of adeno-associated viral vectors.

Authors:  Garrett Edward Berry; Aravind Asokan
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.